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Dopamine in the striatum is known to be important for reversal learning. However,
the striatum does not act in isolation and reversal learning is also well-accepted to
depend on the orbitofrontal cortex (OFC) and the amygdala. Here we assessed whether
dopaminergic drug effects on human striatal BOLD signaling during reversal learning
is associated with anatomical connectivity in an orbitofrontal-limbic-striatal network, as
measured with diffusion tensor imaging (DTI). By using a fiber-based approach, we
demonstrate that dopaminergic drug effects on striatal BOLD signal varied as a function
of fractional anisotropy (FA) in a pathway connecting the OFC with the amygdala.
Moreover, our experimental design allowed us to establish that these white-matter
dependent drug effects were mediated via D2 receptors. Thus, white matter dependent
effects of the D2 receptor agonist bromocriptine on striatal BOLD signal were abolished
by co-administration with the D2 receptor antagonist sulpiride. These data provide
fundamental insight into the mechanism of action of dopaminergic drug effects during
reversal learning. In addition, they may have important clinical implications by suggesting
that white matter integrity can help predict dopaminergic drug effects on brain function,
ultimately contributing to individual tailoring of dopaminergic drug treatment strategies in
psychiatry.
Keywords: dopamine, striatum, amygdala, OFC, reversal learning, diffusion tensor imaging, bromocriptine,
sulpiride
INTRODUCTION
Adequate dopamine neurotransmission is well-known to be
important for reward and reversal learning and accumulating
evidence indicates that the effects of dopamine on such learn-
ing implicate the striatum. Consistent with current theoretical
modeling work (Badre and Frank, 2012), pharmacological func-
tional magnetic resonance imaging (fMRI) studies have revealed
dopaminergic drug effects on striatal BOLD signals during rever-
sal learning (Cools et al., 2001, 2007; Dodds et al., 2008; Van Der
Schaaf et al., 2012). In addition, positron emission tomography
(PET) studies have demonstrated that reversal learning depends
on striatal dopamine synthesis capacity (Cools et al., 2009) and
D2 receptor availability in the striatum (Groman et al., 2011).
However, the striatum does not act in isolation and rever-
sal learning is also well-accepted to depend on the interaction
between striatum, orbitofrontal cortex (OFC) and amygdala
(Iversen and Mishkin, 1970; Jones and Mishkin, 1972; Holland
and Gallagher, 2004; Schoenbaum et al., 2009; Murray and Wise,
2010). This interaction is thought to be modulated by dopamine.
Specifically, medium spiny neurons in the striatum and amygdala
that receive glutamatergic projections from limbic and cortical
regions also receive converging dopaminergic projections from
the midbrain (Pennartz et al., 1994; Rosenkranz and Grace,
2002a; Sesack et al., 2003; Haber and Knutson, 2010). Animal
studies have suggested that the effects of dopamine on these glu-
tamatergic inputs are receptor specific, such that orbitofrontal
inputs to the striatum are modulated by D2 receptor stimulation
(Del Arco et al., 2007; Grace et al., 2007; Del Arco andMora, 2009;
Sesack and Grace, 2010) while orbitofrontal inputs to the amyg-
dala and amygdala inputs to the striatum are modulated by D1
receptor stimulation (Rosenkranz and Grace, 2002b; Ambroggi
et al., 2008; Sesack and Grace, 2010). These observations have
led to the suggestion that dopamine regulates the degree to which
the striatum, amygdala andOFC interact to integrate information
about reward value, motivation and expectation and to ultimately
facilitate adaptive and flexible behavior (Grace et al., 2007; Haber
and Knutson, 2010; Pennartz et al., 2011).
Here we aim to provide evidence for such network effects
of dopamine during human reversal learning by revisiting our
recent pharmacological fMRI study that showed dopaminergic
drug effects on striatal BOLD signal during reversal learning
(Van Der Schaaf et al., 2012). Specifically, we ask whether these
previously reported effects of dopamine on the striatum during
reversal learning are associated with anatomical connectivity in an
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orbitofrontal-limbic-striatal network, as measured with diffusion
tensor imaging (DTI). A demonstration that drug effects are asso-
ciated with individual differences in anatomical connectivity will
not only address the question about whether dopamine’s effects
are associated with an orbitofrontal-limbic-striatal network of
regions, but will also help elucidate individual trait factors that
contribute to the known large variability in dopaminergic drug
effects (Cools and D’esposito, 2011). Thus, individual differences
in anatomical connections between the OFC, amygdala and stria-
tum might predict the extent and direction of dopaminergic drug
effects on reversal learning.
DTI is a non-invasive method to measure structural connec-
tivity in humans. It measures the diffusion of water in tissue,
which depends on the tight packing of cellular axons and myelin
sheets that encapsulate the axon fibers. Two measures are gen-
erally obtained; fractional anisotropy (FA) and mean diffusivity
(MD). FA is a measure of the directionality of water diffusion
and has been associated with dense coherent bundling and myeli-
nation of axons. MD reflects the general presence of barriers to
free diffusion and has been associated with overall cell density.
Collectively, FA and MD provide information on the microstruc-
tural integrity and communicational efficacy of white matter fiber
bundles (Beaulieu, 2002; Thomason and Thompson, 2011).
The hypothesis that individual differences in functional effects
depend on anatomical connectivity as measured with DTI is
grounded in prior work linking anatomical connectivity with
individual differences in functional effects (Boorman et al., 2007;
Cohen et al., 2008; Harsay et al., 2011; Samanez-Larkin et al.,
2012). In addition, we have previously shown that dopamin-
ergic drug effects on striatal BOLD signals during attention-
shifting are associated with white matter integrity of dorsal
fronto-striatal-thalamic pathways (Van Schouwenburg et al.,
2013). These results concur with the known role of dorsal
fronto-striatal-thalamic pathways in cognitive functions such as
attention shifting (Dias et al., 1996). By contrast, reversal learn-
ing depends on a ventral orbitofronto-limbic-striatal network
(Dias et al., 1996). In the present study we used a fiber based
approach (Mandl et al., 2012) to substantiate the observation
that dopaminergic drug effects can be predicted from anatomi-
cal connectivity, while also showing the neuroanatomical speci-
ficity of such findings. Based on the literature reviewed above,
we predict that drug effects on striatal BOLD signal during
reversal learning will depend on a ventral orbitofronto-limbic-
striatal network and not on a dorsal fronto-thalamic-striatal
network.
A final aim of this study was to assess the receptor speci-
ficity of the effects (Feldman et al., 1997). As described above,
work with experimental animals has suggested that the dopamin-
ergic modulation of interactions between the OFC, amygdala
and striatum is dopamine receptor specific (Rosenkranz and
Grace, 2002b; Del Arco et al., 2007; Grace et al., 2007; Ambroggi
et al., 2008; Del Arco and Mora, 2009; Sesack and Grace, 2010).
In addition, it has been demonstrated that reversal learning
in monkeys specifically depends on D2 and not D1 recep-
tor functioning (Lee et al., 2007). To address this issue in
humans we employed a coadministration design. All subjects
were scanned on four occasions: after administration of placebo;
after administration of the dopamine D1/D2 receptor agonist
bromocriptine; after administration of the dopamine D2 recep-
tor antagonist sulpiride; and after combined administration of
both sulpiride and bromocriptine. If drug effects are mediated
by D2 receptors, then any significant effect of bromocriptine
relative to placebo should be abolished by coadministration of
sulpiride. If effects of bromocriptine are mediated by D1 recep-
tors, then they should not be abolished by coadministration of
sulpiride.
METHODS
SUBJECTS
The present study represents an extension of a previously pub-
lished pharmacological fMRI study (Van Der Schaaf et al., 2012)
with diffusion tensor images that were acquired from the same
subjects during an intake session prior to the drug sessions.
For this study, 28 healthy right handed volunteers with no rel-
evant medical/psychiatric history 3 years prior to testing were
tested after a medical screening [for screening procedure and
exclusion criteria see Van Der Schaaf et al. (2012)]. They gave
written informed consent approved by the local ethics commit-
tee (Commissie mensgebonden onderzoek, Arnhem-Nijmegen,
number 2008/078, date 09-09-2008) and were compensated for
participation. In total, 8 subjects were excluded from the fMRI
analysis due to personal issues (1), technical issues (4), excessive
head movement (2) and insufficient practice of the Dutch lan-
guage (1) [see Van Der Schaaf et al. (2012) for further details on
these exclusions]. Complete datasets including both DTI and all
four fMRI sessions were available for twenty subjects (10 males,
mean age: 22.7, range: 18.9–29.1).
PROCEDURES AND PHARMACOLOGICAL DESIGN
Subjects were tested on four occasions, separated by at least 1
week. They were tested after oral intake of placebo, bromocrip-
tine (Parlodel, Novartis®, 1.25mg), sulpiride (Dogmatil, sanova-
aventis®, 400mg), and a combination of bromocriptine and
sulpiride (sulpiride was administered 30min prior to bromocrip-
tine). Administration was randomized according to a counterbal-
anced, placebo controlled, double blind, double dummy design.
The reversal learning task started 2¼h after first drug intake with
a duration of 60min. Blood pressure, heart rate and subjective
mood ratings [visual analog scales (Bond and Lader, 1974)] were
taken 30min before, 2 h after and 6 h after first drug intake. Blood
samples were taken to determine the change in prolactin lev-
els (Fitzgerald and Dinan, 2008) and were taken 30min before
and 2 h after first drug intake. Background neuropsychologi-
cal tests (block completion, number cancellation, verbal fluency
and digit span) were assessed 5 h after first drug intake. Drug
effects on physiological measures were as expected with prolactin
increases after intake of sulpiride and combined administra-
tion and prolactin and systolic blood pressure decreases after
intake of bromocriptine. Analyses of the questionnaires and back-
ground neuropsychology are described in our previous report and
revealed no significant drug effects on mood or general cognitive
functioning. For further details on the screening and session pro-
cedures, physiology, mood and background neuropsychology see
(Van Der Schaaf et al., 2012).
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REVERSAL LEARNING TASK
On each trial, subjects were presented with two simultaneously
presented vertically adjacent stimuli, a face and a scene (location
randomized). One of these stimuli was associated with reward
and the other with punishment. One of the stimuli was selected
by the computer (highlighted with a black border) and subjects
were asked to predict the outcome associated with this prese-
lected stimulus. After the prediction, indicated with a right index
or middle finger button press (counterbalanced across subjects),
the actual outcome was presented (100% deterministic). Note
that these outcomes did not depend on subjects’ responses but
were directly coupled to the highlighted stimulus. The stimulus-
outcome contingencies reversed after 4, 5, or 6 consecutive correct
predictions. Such reversals were signaled by either an unexpected
punishment (presented after a previously rewarded stimulus was
highlighted) or an unexpected reward (presented after a previ-
ously punished stimulus was highlighted). On the trials directly
following these unexpected outcomes (reversal trials), the same
stimulus was highlighted again such that requirements for motor
switching and prediction updating were matched between reward
and punishment conditions. Accuracy on these reversal trials
reflects howwell-subjects updated stimulus-outcome associations
after either unexpected rewards or unexpected punishments. The
dependent variables used for the current report were striatal
BOLD signaling during unexpected outcomes and the proportion
of correct responses on reversal trials (see below).
IMAGE ACQUISITION AND PREPROCESSING
Structural images were collected before the start of the experi-
ment during screening using a 3-tesla Siemens MRI scanner with
an 8 channel head coil. For each subject, a high resolution T1-
weighted MP-RAGE anatomical scan (TE/TR = 3.03/2300ms,
flip angle = 8◦, FOV = 256mm × 256mm × 192mm, voxel size
= 1mm isotropic, GRAPPA acceleration factor 2) was obtained.
Diffusion tensor images were acquired using a twice refocused
spin-echo-planar imaging sequence to reduce spatial distortions
caused by eddy currents (Reese et al., 2003). Sixteen subjects were
scanned with the following protocol: 64 slices interleaved acqui-
sition mode (TE/TR = 89/6700ms, flip angle = 90◦, FOV =
220mm, voxel size = 2.2mm isotropic). Acquisition consisted
of 7 images without diffusion weighting (b = 0) and 61 images
with diffusion weighting (b = 1000 s/mm2) applied along the
non-colinear directions. Four subjects were scanned with slightly
modified protocol in which the TR was 8500ms and images were
acquired with partial instead of full Fourier with a slightly lower
band width.
Raw diffusion weighted imaging (DWI) data were pre-
processed using in-house software (Zwiers, 2010). The DTI
images were realigned using rigid body transformations and
mutual information as a cost function (SPM8). Susceptibility
induced echo-planar imaging distortions were corrected by
warping the images along the phase-encoding direction to the
distortion-free T1 reference images (Studholme et al., 2000)
using an in-house developed implementation (Visser et al., 2010).
Diffusion tensors were then estimated using a robust artifact-
insensitive compute algorithm (Zwiers, 2010). FA and MD mea-
sures were computed from the diffusion tensor eigenvalues. FA
and MDmaps were normalized to the T1 ICBM-template (MNI-
space) using the unified segmentation parameters of the co-
registered structural image. Images were then smoothed with a
Gaussian kernel of 8mm full width half maximum and masked
with a full brain mask. Imaging parameters, pre-processing and
analysis of the functional images, obtained during the drug ses-
sions, are described elsewhere (Van Der Schaaf et al., 2012).
GENERAL ANALYSIS STRATEGY
In our prior work we reported dopaminergic drug effects on stri-
atal BOLD signal during reward and punishment reversal learning
(Van Der Schaaf et al., 2012). These BOLD effects were centered
on the ventral lateral putamen, a region that receives convergent
inputs from both OFC and the amygdala (Draganski et al., 2008;
Haber and Knutson, 2010). Here, we revisit our data and ask
whether the observed dopaminergic drug effects on striatal BOLD
signaling is associated with anatomical connections between the
striatum, OFC and amygdala. Thus, we investigated individual
differences in white matter integrity of anatomical pathways in
an orbitofronto-limbic-striatal network, as indexed by diffusion
tensor images that were acquired from the same subjects during
an intake session prior to the drug sessions.
We used a fiber-based approach (Mandl et al., 2012) and
focused on three anatomical white matter pathways of interest—
(1) a pathway connecting the OFC with the striatum (Ongür and
Price, 2000; Ogar and Gorno-Tempini, 2007; Haber and Knutson,
2010; Balleine et al., 2011), (2) a pathway connecting the amyg-
dala with the striatum (Robbins et al., 1989; Everitt et al., 1991;
Ambroggi et al., 2008), and (3) a pathway connecting the OFC
with the amygdala (Baxter et al., 2000; Stalnaker et al., 2007)—,
and one anatomical white matter pathway of no interest for con-
trol purposes [a pathway connecting the dorsal PFC (dPFC) with
the striatum (Haber and Knutson, 2010)]. As described in the
introduction, this additional pathway was included to demon-
strate specificity of the effects to orbitofronto-limbic-striatal
pathways, involved in reward processing and stimulus-outcome
valuation. Thus, we anticipated that any effects would not extend
to dorsal fronto-striatal pathways that have instead been associ-
ated with more cognitive processes and motor control (Alexander
et al., 1990; Haber and Knutson, 2010). These study-specific
anatomical volumes of interest were first created using probabilis-
tic tractography (see probabilistic tractography section below)
and average FA and MD values were extracted from each path-
way. These FA and MD values were then used as independent
predictor variables in multiple regression analyses with the drug-
related change in striatal BOLD signal during reversal learning as
the dependent variable (see statistical analysis section below).
DEPENDENT VARIABLE I: SELECTION OF STRIATAL BOLD SIGNAL
Striatal BOLD signal was extracted for each drug session from
the locus that exhibited the significant drug effect during rever-
sal learning, as reported previously (Van Der Schaaf et al., 2012).
This drug effect was centered on the left ventral putamen (x, y,
z = −22, 18, 4, pfwe = 0.03) (Figure 2A) and reflected opposite
modulation by the dopamine receptor antagonist sulpiride and
the dopamine receptor agonist bromocriptine of BOLD signal
change during unexpected relative to expected outcomes. Mean
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beta estimates from this peak voxel were extracted with MarsBar
software (Brett et al., 2002) for each drug session. The use of such
a functionally defined timeseries is justified because the aim of
our investigation was to account for variability in exactly this
signal. Drug-related change in the extracted beta-values (rep-
resenting signal during unexpected vs. expected outcomes) was
then used as a dependent variable in linear regression analysis
with the DTI-measurements as predictor variables (see below).
DEPENDENT VARIABLE II: SELECTION OF THE BEHAVIORAL VALUES
The behavioral measures of interest were the valence-dependent
and valence-independent reversal learning scores. These were cal-
culated by computing, respectively, the difference between, and
the average of the proportion of correct responses on reward
and punishment reversal trials. The accuracy scores were arc-
sine transformed [2 × arcsine(√x)] as is appropriate when the
variance is proportional to the mean (Howell, 1997).
PROBABILISTIC TRACTOGRAPHY: SELECTION OF
FRONTAL-STRIATAL-LIMBIC PATHWAYS
Orbitofronto-limbic-striatal pathways are not yet included in
white matter atlases. Accordingly, these study-specific anatom-
ical pathways were created using probabilistic tractography
as implemented in FMRIB’s diffusion toolbox [See also (De
Zeeuw et al., 2012; Mandl et al., 2012; Peper et al., 2013)
for similar procedures]. In total four pathways were created;
OFC—striatum, OFC—amygdala, amygdala—striatum and dor-
sal PFC—striatum. Masks used for tractography were defined
in standard space using the AAL-template (Tzourio-Mazoyer
et al., 2002) (Figure1A). Because the locus of the drug effects
was centered on the left striatum we focussed our analysis on
pathways in the left hemisphere. The left amygdala was defined
as AAL-region 41, the left OFC as the gyrus rectus and orbito
gyrus regions (Ogar and Gorno-Tempini, 2007) (AAL-regions
5, 9, 15, 25 and 2), the left dPFC as all left superior, middle
and inferior frontal gyrus regions (AAL-regions 3, 7, 13, 23)
and the left striatum as the left putamen and caudate nucleus
(AAL-regions 71 and 73). Ventral and dorsal striatal subregions
are not clearly separated by anatomical boundaries and best
defined by its afferent projections from cortical areas (Haber and
Knutson, 2010). Accordingly, we seeded our tractography from
the OFC, dPFC and amygdala and used the whole striatum as
waypoint mask.
For each pathway, waypoint (a.k.a. inclusion) and exclusion
masks were defined as followed: (1) OFC-Striatum: Seed = OFC,
waypoint = striatum, exclusion = dPFC, amygdala and planes
excluding x > 1 and y < −18. (2) Amygdala-Striatum: Seed =
amygdala, waypoint = striatum, exclusion = OFC, dPFC and
planes excluding x > 1 and y < −18. (3) OFC-Amygdala: Seed
= OFC, waypoint = amygdala, exclusion = dPFC, striatum,
and planes excluding x > 1, and y < −18. (4) dPFC-striatum:
Seed dPFC, waypoint: striatum, exclusion: OFC, amygdala and
planes excluding x > 1 and y < −18. These masks were brought
back into native space, using the inverse of the computed nor-
malization parameters to create individual probabilistic diffusion
pathways. Using FMRIB’s diffusion toolbox [FMRIB’s Software
Library (FSL), bedpostx], fiber orientation probabilistic density
functions were estimated at each voxel, allowing for multiple fiber
directions (Behrens et al., 2007). Five thousand streamline sam-
ples per seed voxel were drawn through the probability density
functions to form an estimate of the probability distribution of
connections from each seeded voxel (“probtrackx” with a cur-
vature threshold of 0.2). All pathways from the seed region that
passed through the exclusion mask and all pathways that did not
pass through the waypoint mask were discarded from the calcu-
lation of the connectivity distribution. The resulting connectivity
distribution files are images in which the values at each voxel rep-
resent the number of samples between the seed and waypoint
mask that passed through that voxel. These images were then
brought back to standard space, using individual normalization
parameters, thresholded to include voxels through which at least
1% of the samples passed, binarized and summed across subjects.
FIGURE 1 | Fronto-striatal-limbic pathways. (A) Seed and waypoint masks
that were used for probabilistic tractography, displayed on a MNI-template.
(B) The four study-specific anatomical ROIs used for FA and MD data
extraction. Colored masks represent the binarized group masks for pathways
that were present in at least 75% of all subjects. Abbreviations: dPFC, dorsal
prefrontal cortex; OFC, Orbitofrontal cortex.
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The 4 study-specific anatomical VOI’s were created at the group
level representing those pathways that were present in at least 75%
of all subjects (Figure 1B). These are commonly used thresholds
and are similar or more conservative compared with thresholds
used in other fibre-based DTI tractography studies (Leh et al.,
2007; Gutman et al., 2009; Mandl et al., 2012; Peper et al., 2013).
Finally, the individual mean FA and MD values were extracted
from each pathway.
STATISTICAL ANALYSIS
Because we used different scanning protocols, the extracted FA
and MD values of each pathway were first residualized with
respect to protocol. Multiple linear regression analysis (SPSS, ver-
sion 19.0.0) was done with the residualized FA values from the
four pathways as predictor variables and the drug-related differ-
ence in beta values (BOLD) as dependent variable. A stepwise
procedure was applied to include only those predictors that sig-
nificantly contributed the model. The probability to enter or
remove a predictor was set at 0.05 and 0.1, respectively (default).
Consistent with our previous report, assessments of the differ-
ent drug comparisons were done in a fixed a priori defined
order. First, we investigated which of the pathways contributed
to the effects of dopamine receptor stimulation (bromocriptine)
relative to dopamine receptor blockade (sulpiride) on striatal
BOLD. Next, for the pathways that were revealed in the first step,
we assessed whether their contribution was driven by effects of
bromocriptine relative to placebo or by effects of sulpiride relative
to placebo. Finally, to establish the D2 receptor dependency of the
observed effects, we assessed whether they were blocked by com-
bined administration. The same procedures were used to assess
associations between drug effects on behavior and FA values from
these pathways. To further support the nature of our FA findings
we also assessed the association between drug effect on BOLD and
MD values in the pathways that yielded a significant relationship
from the analysis described above. While FA values represent the
orientation-dependence of water diffusion, which is directional in
white matter fibers, MD values represent the overall magnitude
of water diffusion. MD depends on fiber and membrane density
and, in white matter, increases in MD have been associated with
the degeneration of fiber bundles (Beaulieu, 2002; Thomason and
Thompson, 2011). Accordingly, when, across subjects, higher FA
values in white matter are accompanied by lower MD values,
this likely reflects higher levels of fiber and membrane density
within non-crossing fiber bundles. Conversely, when across sub-
jects, higher FA values are accompanied by higher MD values,
this possibly reflects selectively lower levels of fiber and mem-
brane density within of one of the fiber bundles in a crossing fiber
region.
Finally, for completion, main effects of drugs on behavior were
assessed with repeated measures ANOVAwith the within-subjects
factors drug and valence (reward and punishment). The order of
drug comparisons were assessed in the same a priori defined order
as described above.
SUPPLEMENTARY ANALYSIS
In addition to the volume of interest analyses, we conducted
supplementary voxel-wise regression analysis at the whole-brain
level, using random effects multiple regression procedures in
SPM8 (http://www.fil.ion.ucl.ac.uk/spm). This allowed us to
visualize the (physiological plausibility of) effects that were
revealed to be statistically significant using the volume of inter-
est analyses. To this end, individual FA-maps were submitted to
a second-level one sample T-test and the drug-related changes in
striatal BOLD signal were entered as a covariate of interest. Scan-
protocol was entered as a covariate of no-interest. Voxels revealed
by the covariate of interest represent white matter regions that
exhibit a linear relationship between individual FA-values and
drug effects on striatal BOLD. Effects are displayed for visual-
ization purposes only at a threshold of p < 0.001 uncorrected
for multiple comparisons (Figure 3). Next, probabilistic diffusion
tractography (FMRIB’s diffusion toolbox) was used to visualize
the pathways connecting with the FA region revealed by the voxel-
wise regression analysis as a seed. To this end, the FA seed region
was defined as a 4mm sphere around the peak voxel of the FA
region (x, y, z = −34, 8, −6) revealed by the regression anal-
ysis. For each subject, this region was brought back into native
space, using the inverse of the computed normalization parame-
ters and used as a seed region for probabilistic tractography (same
settings as above). The resulting connectivity distribution images
were brought back to standard space, using individual normal-
ization parameters, and tractography maps were thresholded to
include only voxels through which at least 1% of all samples had
passed. These individual maps were then binarized and summed
across subjects to produce group probability maps.
RESULTS
Linear regression analysis revealed a significant positive relation-
ship between drug effects on striatal BOLD (bromocriptine—
sulpiride) and FA values from the OFC-amygdala pathway
[F(1, 19) = 8.33, R2 = 0.32, adjusted R2 = 0.28, β = 0.56, T =
2.89, p = 0.010]. No significant contribution of the OFC-
striatum (β = 0.06, T = 0.22, p = 0.82), dPFC-striatum (β =
0.01, T = −0.03, p = 0.98) or the amygdala-striatum path-
ways (β = −0.04, T = −0.18, p = 0.86) were revealed. FA val-
ues from the OFC-amygdala pathway were associated with the
effects of bromocriptine relative to placebo on striatal BOLD
[F(1, 19) = 5.63, R2 = 0.24, adjusted R2 = 0.19, β = 0.48, T =
2.37, p = 0.029], but not of sulpiride relative to placebo (beta
= −0.14, p = 0.55). Moreover, these white-matter dependent
effects of bromocriptine on striatal BOLD were abolished by
co-administration of both drugs; FA-values from the OFC—
amygdala pathway correlated significantly with the effects of
bromocriptine relative to combined administration on striatal
BOLD [F(1, 19) = 10.73, R2 = 0.37, adjusted R2 = 0.34, β =
0.61, T = 3.28, p = 0.004], but not with the effects of placebo rel-
ative to combined administration on striatal BOLD (β = −0.23,
p = 0.34) (Figure 2B).
Subsequent correlation analyses with MD-values from the
OFC–amygdala pathway revealed a negative relationship between
the effect of bromocriptine relative to sulpiride on striatal BOLD
and MD-values from the OFC-amygdala pathway (β = −0.61,
p = 0.004). Thus, the found associations with FA were accompa-
nied by associations with fiber density within the OFC-amygdala
pathway. Taken together, these data show that bromocriptine
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increased reversal-related striatal BOLD in subjects with high
FA-values in the OFC-amygdala pathway, while it decreased stri-
atal BOLD in subjects with low FA-values in this pathway. These
effects were likely mediated via D2 receptor stimulation, as effects
were abolished by co-administration with sulpiride.
There were no associations between FA-values and drug
effects (reported here are effects of bromocriptine relative
to placebo) on behavioral measures of valence-dependent
reversal learning (OFC-amygdala: β = −0.10, p = 0.68; OFC-
striatum: β = −0.23, p = 0.34; dPFC-striatum: β = −0.03, p =
0.89; Amygdala-striatum: β = −0.27, p = 0.25) or valence-
independent reversal learning (OFC-amygdala: β = −0.34, p =
0.14; OFC-striatum: β = −0.23, p = 0.33; dPFC-striatum: β =
−0.25, p = 0.30; amygdala-striatum: β = −0.06, p = 0.81).
For completeness, we also assessed drug effects on behavior
irrespective of FA values. This revealed a trend toward opposite
effects of bromocriptine and sulpiride on reward and punishment
reversal learning [drug× valence: F(1, 19) = 4.2, P = 0.054]. This
was due to better punishment relative to reward learning after
bromocriptine (raw accuracy scores ± standard error of the
mean: reward: 0.90 ± 0.02; punishment: 0.92 ± 0.01), but better
reward relative to punishment learning after sulpiride (reward:
0.93 ± 0.02; punishment: 0.90 ± 0.02). However, no drug by
valence effects were seen when comparing bromocriptine with
placebo (reward: 0.90 ± 0.02; punishment: 0.89 ± 0.03) [drug ×
valence: F(1, 19) = 1.8, P = 0.20].
SUPPLEMENTARY ANALYSES
Results from the brain-wide voxel wise regression analy-
ses and subsequent tractography concurred with the results
from the volumes of interest analyses reported above. Thus,
brain-wide analysis revealed that FA in a region within the
uncinate fasciculus, as identified with the JHU white mat-
ter tractography atlas, predicted drug effects on striatal BOLD
signal (bromocriptine—sulpiride: x, y, z = −34, 8, −6, T =
4.87, punc < 0.001; bromocriptine—placebo: x, y, z = −30,
10, −8, T = 3.84, punc < 0.001; bromocriptine-combined: x, y,
z = −26, 4, −12, T = 6.51, punc < 0.001) (Table 1, Figure 3A).
Probabilistic tractography from this region revealed an extended
network of pathways between the OFC, amygdala and striatum.
Other pathways revealed by tractography included connections
with the insular cortex and a pathway along the inferior longitudi-
nal fasciculus along the hippocampus and toward the visual cor-
tex. No pathways toward the thalamus or midbrain regions were
seen. These tractography findings further support that our find-
ings likely involve white matter integrity in the OFC-amygdala
pathway, rather than direct fronto-striatal pathways, as the latter
Table 1 | Whole brain results from the voxel-wise regression analysis
of FA regions that showed a linear correlation with drug effects on
striatal BOLD.
Side N voxels T -value MNI
x y z
BROMOCRIPTINE—SULPIRIDE (POSITIVE)
L 14 5.12 −34 0 42
L 35 4.87 −34 8 −6
R 16 4.77 26 40 14
L 13 4.43 −10 38 46
L 17 4.34 −30 −20 −46
BROMOCRIPTINE—PLACEBO (POSITIVE)
R 13 5.32 16 −28 44
L 73 3.84 −30 10 −8
BROMOCRIPTINE—COMBINED(POSITIVE)
L 196 6.51 −26 4 −12
L 14 4.48 −30 −14 −46
L 11 3.93 −18 −54 12
The regions that fell within our anatomically defined pathways are printed in bold.
Data is presented with p < 0.001 uncorrected and extended threshold of >10
voxels.
FIGURE 2 | Relationship between drug effects on BOLD and FA-values,
revealed by ROI analyses. (A) Shown are effects of bromocriptine relative to
sulpiride on striatal BOLD signal during unexpected outcomes in the reversal
learning task [(unexpected—expected rewards) + (unexpected—expected
punishments)] (x, y, z = −22, 18, 4, pfwe_striatum = 0.03). These effects were
reported previously in Van Der Schaaf et al. (2012) and depended on working
memory capacity. (B) Linear relationship between FA values in the
OFC-amygdala pathway and the effects of bromocriptine relative to sulpiride
(left), bromocriptine relative to placebo (middle) and bromocriptine relative to
combined administration of both drugs (right) on striatal BOLD. Only significant
effects are shown. ∗p < 0.05 Abbreviations: Pla, placebo; Bro, bromocriptine;
Sul, sulpiride; SB = combined administration of bromocriptine and sulpiride.
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FIGURE 3 | Relationship between drug effects on BOLD and FA-values,
revealed by whole brain analyses. (A) White matter regions showing a
linear relationship between FA-values and the effects of bromocriptine
relative to sulpiride (left), bromocriptine relative to placebo (middle) and
bromocriptine relative to combined administration of both drugs (right) on
striatal BOLD. (B) Summed tractography maps of the individual pathways
that originate from the FA-region displayed in Figure 3A (left). Probabilistic
tractography from this region revealed an extensive network of pathways
between the OFC, amygdala and striatum. Image is thresholded to present
those tracks that were present in at least 25% of the subjects.
typically also involve thalamic connections (Haber and Knutson,
2010) (Figure 3B).
DISCUSSION
Dopaminergic drug effects have been shown to vary greatly
between individuals (Cools and D’esposito, 2011). Here we pro-
vide evidence for an important link between dopaminergic drug
effects during reversal learning and neuroanatomical integrity
of connections between the OFC and amygdala. More specifi-
cally, we demonstrate that dopaminergic drug effects on striatal
BOLD signal during reversal learning vary as a function of FA
and MD in a pathway connecting the OFC with the amygdala.
FA and MD rely on several microstructural properties, includ-
ing the level of axon myelination, intact axonal membranes
and fiber density (Beaulieu, 2002). Accordingly, our results sup-
port the hypothesis that dopaminergic drug effects on human
striatal BOLD signal are associated with the neuronal commu-
nication efficiency of cortico-limbic projections. The implication
of these findings is 2-fold. First, the data provide fundamental
insight into themechanism of action of dopaminergic drug effects
on reward-related processing and reversal learning. Specifically,
effects of D2 receptor stimulation during reversal learning involve
an orbitofronto-limbic-striatal network. Second, they may have
important clinical implications by suggesting that measures of
white matter integrity can help predict dopaminergic drug effects
on brain function, thus contributing ultimately to the indi-
vidual tailoring of dopaminergic drug treatment strategies in
psychiatry.
The drug effects on striatal BOLD signal were associated with
white matter integrity of the pathway connecting the OFC with
the amygdala (i.e., part of the uncinate fasciculus), and not
by that of direct orbitofronto-striatal or amygdala-striatal pro-
jections. These findings extend previous non-pharmacological
human DTI studies demonstrating that reward-related striatal
BOLD responses (Camara et al., 2010) and associated functional
connectivity (Cohen et al., 2008) are associated with white matter
integrity of orbitofrontal-limbic-striatal pathways. Furthermore,
we also showed that the drug effects during reversal learn-
ing were not associated with white matter integrity of dorsal
fronto-striatal connections, which are suggested to be involved
in more cognitive and motor processing (Alexander et al., 1990;
Haber and Knutson, 2010). Indeed, our findings complement
those from a recent study (Van Schouwenburg et al., 2013), in
which we demonstrated that white matter integrity of a dorsal
fronto-striatal-thalamic pathway was associated with drug effects
on striatal BOLD signals during a form of attention-shifting
that did not involve reward. Together, these data establish that
associations between dopaminergic drug effects and white mat-
ter integrity are neuroanatomically specific and depend on task
demands.
Our results are consistent with animal lesion work that has
repeatedly demonstrated the crucial role of OFC-amygdala inter-
actions in reversal learning (Baxter et al., 2000; Stalnaker et al.,
2007; Schoenbaum et al., 2009). TheOFC has originally been sug-
gested to rapidly encode new associations and regulate reversal
learning by directly driving areas such as the striatum (Thorpe
et al., 1983). However, accumulating evidence indicates that the
OFC instead contributes indirectly to the updating of stimulus-
outcome associations by providing information about expected
outcomes to other down-stream areas such as the amygdala
(Stalnaker et al., 2007; Schoenbaum et al., 2009; Takahashi et al.,
2009). Amygdala projections to the ventral striatum might then,
in turn, mediate the effects of (updated) outcome-predictive
stimuli on action selection. Indeed, electrophysiological responses
in the ventral striatum (and associated behavioral responding)
to relevant sensory stimuli critically depend on concomitant
amygdala and dopamine inputs (Robbins et al., 1989; Everitt
et al., 1991; Ambroggi et al., 2008; Pennartz et al., 2011).
Accordingly, our results highlight the importance of indirect
OFC-amygdala pathways in reversal learning by showing that
dopaminergic modulation of striatal BOLD responses during
reversal learning are not associated with white matter integrity
of direct fronto-striatal pathways, but instead are associated with
white matter integrity of the OFC-amygdala pathway. Together,
these results provide fundamental insight into the mechanism
by which dopamine changes brain function during reversal
learning.
In addition, our experimental design allowed us to establish
that these white-matter dependent drug effects were mediated by
D2 receptors. Effects of the D2 receptor agonist bromocriptine
on striatal BOLD signal were abolished by co-administration with
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the D2 receptor antagonist sulpiride. This generally concurs with
animal work demonstrating that reversal learning in monkeys
is selectively mediated by D2 receptors but not D1 receptors
(Lee et al., 2007). In addition, animal work has demonstrated
that the effects of dopamine on the output of amygdala neurons
are at least partially mediated by D2 receptors (Rosenkranz and
Grace, 1999, 2002a; Grace and Rosenkranz, 2002; Bissière et al.,
2003). While D2 receptor stimulation was found to potentiate
sensory driven amygdala outputs to the striatum, D1 recep-
tor stimulation was found to attenuate PFC inhibitory influ-
ences on amygdala output neurons (Rosenkranz and Grace,
1999, 2002a). Based on such experimental animal work, we
speculate that bromocriptine potentiated sensory-driven amyg-
dala output excitability to a greater extent in subjects with
high communicational efficacy within the OFC-amygdala path-
way than in those with low OFC-amygdala connectivity. It
might be noted we cannot provide definitive evidence for
this latter hypothesis, because DTI is inconclusive with regard
to the direction in which information travels. Nevertheless,
our results do converge with prior animal work and high-
light the importance of D2 receptor stimulation for reversal
learning.
One caveat of our study is that we did not find evi-
dence for a direct relationship between white matter integrity
of the OFC-amygdala pathway and drug effects on behavioral
updating of stimulus-outcome associations. This is particularly
surprising given that experimental animal work has demon-
strated that the OFC and amygdala (Iversen and Mishkin,
1970; Jones and Mishkin, 1972) and their interaction (Baxter
et al., 2000; Stalnaker et al., 2007) are crucial for behav-
ioral performance on reversal learning tasks. Accordingly, we
believe that our failure to observe correlations with drug
effects on behavior might reflect a relative lack of sensitivity.
Future work should reveal whether the present finding that
white matter integrity of orbitofrontal-limbic-striatal pathways
is associated with drug effects on brain function extends to
behavior.
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